Adjunct therapy with probiotics for depressive episodes of bipolar disorder type Ⅰ: A randomized placebo-controlled trial

Background: Probiotics adjuvant therapy might enhance the efficacy of the conventional medications of bipolar disorder type Ⅰ (BD-Ⅰ). Methods: A randomized double-blind placebo-controlled design was implemented in this study. We randomly assigned 98 patients with depressive BD-Ⅰ to receive the combi...

Full description

Bibliographic Details
Main Authors: Jian-zhao Zhang, Fang-yuan Zhu, En-xu Feng, Fei Wu, Xin Fang, Huai-jun Tu, Jin Wei, Ai-lan Wan, Ting-tao Chen
Format: Article
Language:English
Published: Elsevier 2023-06-01
Series:Journal of Functional Foods
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1756464623001536
_version_ 1797819916913475584
author Jian-zhao Zhang
Fang-yuan Zhu
En-xu Feng
Fei Wu
Xin Fang
Huai-jun Tu
Jin Wei
Ai-lan Wan
Ting-tao Chen
author_facet Jian-zhao Zhang
Fang-yuan Zhu
En-xu Feng
Fei Wu
Xin Fang
Huai-jun Tu
Jin Wei
Ai-lan Wan
Ting-tao Chen
author_sort Jian-zhao Zhang
collection DOAJ
description Background: Probiotics adjuvant therapy might enhance the efficacy of the conventional medications of bipolar disorder type Ⅰ (BD-Ⅰ). Methods: A randomized double-blind placebo-controlled design was implemented in this study. We randomly assigned 98 patients with depressive BD-Ⅰ to receive the combined treatment of probiotics (Bifidobacterium animals subsp. lactis BAMA-B06/BAu-B0111, 2 g/day) (N = 49) and conventional medications, or conventional medications along with placebo (maltodextrin, 2 g/day) (N = 49). Primary endpoints were the change from baseline to 30 days in the scores of 17-item Hamilton Depression Rating Scale. Results: Compared with control group, HAMD-14 scores were further decreased significantly and the increase trend of fasting blood glucose were suppressed in treatment group. Subsequent correlation analysis revealed there were close associations between the relative abundance of Firmicutes, serum levels of fasting blood glucose and HAMD-14 scores. Conclusions: Probiotics adjuvant therapy can enhance the efficacy of the conventional medications of depressive BD-Ⅰ and reduce the metabolic side effects.
first_indexed 2024-03-13T09:29:39Z
format Article
id doaj.art-e1329a47d07f4c569dc6e4bc12ef8c28
institution Directory Open Access Journal
issn 1756-4646
language English
last_indexed 2024-03-13T09:29:39Z
publishDate 2023-06-01
publisher Elsevier
record_format Article
series Journal of Functional Foods
spelling doaj.art-e1329a47d07f4c569dc6e4bc12ef8c282023-05-26T04:21:09ZengElsevierJournal of Functional Foods1756-46462023-06-01105105553Adjunct therapy with probiotics for depressive episodes of bipolar disorder type Ⅰ: A randomized placebo-controlled trialJian-zhao Zhang0Fang-yuan Zhu1En-xu Feng2Fei Wu3Xin Fang4Huai-jun Tu5Jin Wei6Ai-lan Wan7Ting-tao Chen8Department of Psychiatry, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, ChinaQueen Mary School, Nanchang University, Nanchang, Jiangxi 330006, ChinaCollege of Food Science and Engineering, Shandong Agricultural University, Taian, Shangdong 271018, ChinaDepartment of Obstetrics and Gynecology, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, ChinaDepartment of Neurology, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, ChinaDepartments of Geriatrics, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330031, ChinaInstitute of Translational Medicine, Nanchang University, Nanchang, Jiangxi 330006, ChinaDepartment of Psychiatry, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, China; Corresponding authors at: Department of Psychiatry, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, China.Department of Psychiatry, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, China; Institute of Translational Medicine, Nanchang University, Nanchang, Jiangxi 330006, China; Corresponding authors at: Department of Psychiatry, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, China.Background: Probiotics adjuvant therapy might enhance the efficacy of the conventional medications of bipolar disorder type Ⅰ (BD-Ⅰ). Methods: A randomized double-blind placebo-controlled design was implemented in this study. We randomly assigned 98 patients with depressive BD-Ⅰ to receive the combined treatment of probiotics (Bifidobacterium animals subsp. lactis BAMA-B06/BAu-B0111, 2 g/day) (N = 49) and conventional medications, or conventional medications along with placebo (maltodextrin, 2 g/day) (N = 49). Primary endpoints were the change from baseline to 30 days in the scores of 17-item Hamilton Depression Rating Scale. Results: Compared with control group, HAMD-14 scores were further decreased significantly and the increase trend of fasting blood glucose were suppressed in treatment group. Subsequent correlation analysis revealed there were close associations between the relative abundance of Firmicutes, serum levels of fasting blood glucose and HAMD-14 scores. Conclusions: Probiotics adjuvant therapy can enhance the efficacy of the conventional medications of depressive BD-Ⅰ and reduce the metabolic side effects.http://www.sciencedirect.com/science/article/pii/S1756464623001536Bipolar disorderProbioticsGut microbiotaAdjunct therapyMetabolic disorders
spellingShingle Jian-zhao Zhang
Fang-yuan Zhu
En-xu Feng
Fei Wu
Xin Fang
Huai-jun Tu
Jin Wei
Ai-lan Wan
Ting-tao Chen
Adjunct therapy with probiotics for depressive episodes of bipolar disorder type Ⅰ: A randomized placebo-controlled trial
Journal of Functional Foods
Bipolar disorder
Probiotics
Gut microbiota
Adjunct therapy
Metabolic disorders
title Adjunct therapy with probiotics for depressive episodes of bipolar disorder type Ⅰ: A randomized placebo-controlled trial
title_full Adjunct therapy with probiotics for depressive episodes of bipolar disorder type Ⅰ: A randomized placebo-controlled trial
title_fullStr Adjunct therapy with probiotics for depressive episodes of bipolar disorder type Ⅰ: A randomized placebo-controlled trial
title_full_unstemmed Adjunct therapy with probiotics for depressive episodes of bipolar disorder type Ⅰ: A randomized placebo-controlled trial
title_short Adjunct therapy with probiotics for depressive episodes of bipolar disorder type Ⅰ: A randomized placebo-controlled trial
title_sort adjunct therapy with probiotics for depressive episodes of bipolar disorder type i a randomized placebo controlled trial
topic Bipolar disorder
Probiotics
Gut microbiota
Adjunct therapy
Metabolic disorders
url http://www.sciencedirect.com/science/article/pii/S1756464623001536
work_keys_str_mv AT jianzhaozhang adjuncttherapywithprobioticsfordepressiveepisodesofbipolardisordertypeiarandomizedplacebocontrolledtrial
AT fangyuanzhu adjuncttherapywithprobioticsfordepressiveepisodesofbipolardisordertypeiarandomizedplacebocontrolledtrial
AT enxufeng adjuncttherapywithprobioticsfordepressiveepisodesofbipolardisordertypeiarandomizedplacebocontrolledtrial
AT feiwu adjuncttherapywithprobioticsfordepressiveepisodesofbipolardisordertypeiarandomizedplacebocontrolledtrial
AT xinfang adjuncttherapywithprobioticsfordepressiveepisodesofbipolardisordertypeiarandomizedplacebocontrolledtrial
AT huaijuntu adjuncttherapywithprobioticsfordepressiveepisodesofbipolardisordertypeiarandomizedplacebocontrolledtrial
AT jinwei adjuncttherapywithprobioticsfordepressiveepisodesofbipolardisordertypeiarandomizedplacebocontrolledtrial
AT ailanwan adjuncttherapywithprobioticsfordepressiveepisodesofbipolardisordertypeiarandomizedplacebocontrolledtrial
AT tingtaochen adjuncttherapywithprobioticsfordepressiveepisodesofbipolardisordertypeiarandomizedplacebocontrolledtrial